Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib in Malignant Pleural Mesothelioma
NCT00513877Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- May 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 4
01
Overview
A Phase 2 trial of bortezomib in malignant pleural mesothelioma (MPM), sponsored by Cancer Trials Ireland. Started May 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00513877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00513877.